Dimabefylline
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161535This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C16H19N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L6V4Z7SX7S, chemically known as 7-(p-dimethylaminobenzyl)-1,3-dimethylxanthine but generally known as dimabefylline, which bears US NIH Compound Identifier 71646. European Medicines Agency schedules Dimabefylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07149MIG. The term DIMABEFYLLINE is an International Non-Proprietary Name. DIMABEFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dimabefylline under HS 29395900 and SITC 54145. As of Q4 2014, DIMABEFYLLINE remains the US FDA Preferred Term for this commodity. Dimabefylline bears US NLM identifiers UMLS ID C1880329 and NCI Concept Code C65392. SMILES: O=C1N(C(=O)N(C2NCN(C12)CC1CCC(N(C)C)CC1)C)C.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.